Skip to main content

Published locations for Post-HCT azithromycin doesn’t increase relapse risk, study suggests

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Post-HCT azithromycin doesn’t increase relapse risk, study suggests

User login

  • Reset your password
  • /content/post-hct-azithromycin-doesnt-increase-relapse-risk-study-suggests
  • /clinicianreviews/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin-doesnt
  • /hematologynews/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin-doesnt
  • /internalmedicinenews/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin
  • /oncologypractice/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin-doesnt
  • /hematology-oncology/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin
  • /hematologytimes/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin-doesnt
  • /internalmedicine/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin-doesnt
  • /chestphysician/article/195493/leukemia-myelodysplasia-transplantation/post-hct-azithromycin-doesnt